Clinical Subgroups in Bilateral Meniere Disease
Top Cited Papers
Open Access
- 24 October 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 7, 182
- https://doi.org/10.3389/fneur.2016.00182
Abstract
Meniere disease (MD) is a heterogeneous clinical condition characterized by sensorineural hearing loss, episodic vestibular symptoms and tinnitus associated with several comorbidities such as migraine or autoimmune disorders (AD). The frequency of bilateral involvement may range from 5-50% and it depends on the duration of the disease. We have performed a two-step cluster analysis in 398 patients with bilateral MD to identify the best predictors to define clinical subgroups with a potential different etiology to improve the phenotyping of bilateral MD and to develop new treatments. We have defined five clinical variants in bilateral MD. Group 1 is the most frequently found, includes 46% of patients, and is defined by metachronic hearing loss without migraine and without AD. Group 2 is found in 17% of patients, and it is defined by synchronic hearing loss without migraine or AD. Group 3, with 13% of patients, is characterized by familial MD, while group 4, that includes 12% of patients, is associated by the presence of migraine in all cases. Group 5 is found in 11% of patients and is defined by AD. This approach can be helpful in selecting patients for genetic and clinical research. However, further studies will be required to improve the phenotyping in these clinical variants for a better understanding of the diverse etiological factors contributing to bilateral MD.Keywords
Funding Information
- Instituto de Salud Carlos III (PI13/1242)
This publication has 74 references indexed in Scilit:
- Functional variants of MIF, INFG and TFNA genes are not associated with disease susceptibility or hearing loss progression in patients with Ménière’s diseaseEuropean Archives of Oto-Rhino-Laryngology, 2012
- High Prevalence of Systemic Autoimmune Diseases in Patients with Menière's DiseasePLOS ONE, 2011
- Proteomics in Ménière diseaseJournal of Cellular Physiology, 2011
- Polymorphisms of CD16A and CD32 Fcγ receptors and circulating immune complexes in Ménière's disease: a case-control studyBMC Medical Genetics, 2011
- Membranous labyrinth volumes in normal ears and Ménière disease: A three‐dimensional reconstruction studyThe Laryngoscope, 2009
- Identifying Tinnitus Subgroups With Cluster AnalysisAmerican Journal of Audiology, 2008
- Possible association between thyroid autoimmunity and Menière's diseaseClinical and Experimental Immunology, 2008
- HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?Expert Reviews in Molecular Medicine, 2005
- Progression of Symptoms of Dizziness in Ménière's DiseaseJAMA Otolaryngology–Head & Neck Surgery, 2004
- PROGRESSION OF HEARING LOSS IN BILATERAL MENIERE??S DISEASEThe Laryngoscope, 1988